AI assistant
Solana Co — Director's Dealing 2015
Nov 12, 2015
32724_dirs_2015-11-12_dee052d5-d3ca-4989-a651-0b2aaf91481f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2015-11-02
Reporting Person: Bapty Brian (Vice President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock, Without Par Value | 282700 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $.70 | 2020-10-28 | Class A Common Stock (400000) | Direct | |
| Stock Option (Right to Buy) | $1.92 | 2017-07-14 | Class A Common Stock (100000) | Direct |
Footnotes
F1: Sixteen percent of the shares subject to this option vested on October 28, 2015 and the remaining shares will vest in equal amounts on each of April 28, 2016, October 28, 2016, April 28, 2017, October 28, 2017, April 28, 2018, and October 28, 2018.
F2: Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00 = CAD$1.3149 on October 28, 2015, based on an option exercise price of CAD$0.84.
F3: The shares subject to this option vested in four equal installments on July 14, 2014, September 30, 2014, December 31, 2014 and March 31, 2015.
F4: Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00 = CAD$1.3149 on October 28, 2015, based on an option exercise price of CAD$2.52.